The landscape of cancer care is changing rapidly. Faster cancer diagnosis is a key ambition of the NHS Long-term Plan, which says that the proportion of cancers diagnosed at stages one and two should rise from around half now, to three quarters of cancer patients by 2028.
Raising greater awareness of the symptoms of cancer, lowering the threshold for referral by GPs, accelerating access to diagnosis and treatment and maximising the number of cancers identified through screening will be key to achieving this goal.
We have put together a collection of key resources that explore the challenges for the NHS and industry in improving cancer diagnosis and care.
[Download] What impact will covid-19 have on the delivery of cancer services?
Prior to the outbreak of the coronavirus pandemic, the Long-term Plan set out ambitious targets to improve cancer outcomes and services in England over the next ten years.
Download our latest oncology report exploring the impact covid-19 will have on cancer services. What patients will be prioritised? What are the new guidelines on chemotherapy and drug treatment? And what other changes to drug treatment may be considered?
[Animation] Impact of diagnostic staging in cancer
The Long-term Plan has set ambitious targets to improve earlier stage diagnosis in cancer.
The NHS has identified a group of clinical priorities, detailed in the Long-term Plan, that have been selected for the considerable impact they can have on improving the population’s health. One of the identified therapy areas is oncology with the plan setting an ambitious target of improving patient outcomes through earlier stage diagnosis.
Explore our free-to-access interactive dashboard, demonstrating how our analytic tools interpret real-world healthcare data into true intelligence and insight.
[Download] Oncology Review
Download our 26-page oncology review exploring the challenge of raising greater awareness of the symptoms of cancer, lowering the threshold for referral by GPs, accelerating access to diagnosis and treatment and maximising the number of cancers identified through screening.
[Video] Join the conversation: Oncology
The alignment of services is essential for the success of so many new cancer products and companion diagnostics and the associated improvement of outcomes for patients benefiting from treatment at an earlier stage. We discuss how important it is to understand the new integrated systems.
[Download] National press supplements
Download the full cancer supplements, recently published in the press, which draw on thoughts of leading thinkers in the field, including Wilmington Healthcare and other industry leaders.
[Download] Innovations in Oncology supplement
The Innovations in Oncology supplement shines a spotlight on the novel innovations that are being used to advance the treatment of oncology and improve patient pathways.
[Download] The Times Combating Cancer supplement
The Times Combating Cancer supplement showcases current trends in oncology, as well as offering insights into the future of treatment.
Our oncology capabilities
Wilmington Healthcare holds contact data on all cancer alliances and all cancer alliance board members. We can also identify cancer stakeholders by subspecialty, from a wide variety of cancer types.
We also provide data across cancer alliances and CCGs on waiting times and diagnostic stages. This data can be visualised via our Quantis product to produce heat maps of where the greatest challenges are, and where such diagnostic waits could be hampering survival from your therapies – plus many other useful presentation tools to help highlight the story you want to take to oncology decision-makers.
Primary Care Networks
As the NHS aims to move more care out of hospitals, Primary Care Networks (PCNs) are expected to play an important role in transforming cancer services. Wilmington Healthcare has comprehensive customer data on these. We also have a variety of resources to help you understand PCNs and support you in aligning your value proposition to their agenda. Learn more.